TrialAdvances in therapy2022

Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial.

Justus G Garweg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.